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Isn’t Limb as Precious as Life?
Prashant N. Mohite and André R. Simon
Abstract
As utilisation of peripheral extra-corporeal life support (ECLS) is becoming 
clinical routine, its associated complications become more frequent. Distal limb 
perfusion in femoral cannulation remains one of the Achille’s heels in patients with 
peripheral ECLS. Unless detected early, limb ischemia may result in loss of limb and 
sometimes life. A protocol-based approach, precautions during ECLS implantation 
and explantation procedures and continuous monitoring of the limb during ECLS 
support are key elements in preventing this complication. Utilisation of a distal limb 
perfusion cannula helps in prevention as well as management of limb ischemia; 
however, it may sometimes cause more damage than help. Management and conse-
quence of limb ischemia essentially depends on its severity at the time of detection 
as well as time of intervention. This chapter offers a brief review of the burden of 
limb ischemia, means to prevent and approaches to manage it.
Keywords: extra-corporeal life support, limb ischemia, complications,  
distal limb perfusion
1. Introduction
Extra-corporeal life support (ECLS) for the last 2–3 decades has become an 
indispensable tool in the armamentarium of physicians and surgeons dealing with 
patients suffering severe cardio-pulmonary failure [1]. Over the period of time, 
its utilisation has seen a broadening in terms of indications, age limits and condi-
tion of patients [2–9]. Familiarisation with technique, continuous improvement of 
equipment and changes in strategy in favour of early intervention have helped to 
improve the survival of patients supported on the ECLS [10, 11]. However, unfor-
tunately, a significant number of patients still suffer and succumb to complications 
instigated by the ECLS. In fact, not very uncommonly, ECLS related complications 
play a decisive role in the clinical outcome of the patient. For the purpose of this 
discussion, we use the term ECLS as a synonym for extra corporeal veno-arterial 
membrane oxygenation. Alternative technologies such Impella® or short term left 
ventricular assist (VAD) are not discussed. Initial ECLS in the acutely presenting 
patients is often implemented via femoral cannulation. Alternative approaches such 
as via the subclavian, axillary or carotid artery are used less commonly in adults 
and the incidence of limb ischemia in these scenarios is negligible compared to 
femoral artery. Therefore, for all practical purposes we will discuss lower extremity 
limb ischemia in this chapter. Late or chronic limb ischemia, sometimes occurring 
months after de-cannulation although symptomatic, seldom threatens limb survival 
and will not be discussed either.
Limb ischemia in patients supported on peripheral ECLS is one of the most dreaded 
complications and presents with a wide spectrum of clinical symptoms and outcomes. 
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Interestingly enough, this specific complication can be almost totally avoided with a 
protocol-based approach and precautions taken during the ECLS support; and if it 
occurs, it can be managed without significant consequences if detected and addressed 
immediately.
1.1 Indications
ECLS, although offered by specialised units only, is becoming more and more 
adopted for treatment of patients presenting with a variety of problems. Recent 
developments in technology have resulted in easier implantation and maintenance, 
ability to implement directly at the bedside, complete cardiopulmonary support and 
cost-effectiveness when compared to other mechanical circulatory support devices.
In surgery, ECLS is utilised as a rescue in post-cardiotomy cardiogenic shock 
(PCCS) or as a temporary prolongation of cardiopulmonary bypass (CPB) to allow 
for an extensive weaning. Historically, the ECLS circuit was connected to the central 
CPB cannulation following unsuccessful weaning attempts of CPB. Recent years 
have seen a paradigm shift in preference to peripheral access. It is because periph-
eral cannulation allows for chest closure and avoids bleeding from high pressure 
aortic and thin-walled right atrial cannulation site and thus, multiple re-explora-
tions for bleeding-temponade. Furthermore, the risk of formation of a positional 
thrombus on the intraluminal part of the aortic cannula, which may be dislodged at 
the time of decannulation and result in a catastrophic embolic event is avoided. And 
lastly, peripheral access obviates reopening of chest at the time of explantation of 
ECLS [2, 3]. Cannulation is either performed percutaneously or open, depending 
on the situation and the presenting patient.
A second group experiencing a significant increase in the utilisation of ECLS 
are patients during primary coronary intervention (PCI) [4, 5], although recent 
developments may lead to a shift in the technology used, such as Impella®. In this 
particular clinical setting, the expertise of interventional cardiologists and avail-
ability of fluoroscopy obviously lends itself to direct percutaneous implementation 
of ECLS. Bed-side, emergency direct ECLS implantation in intensive care units is a 
last and only resort to resuscitate patients after cardiopulmonary arrest undergoing 
prolonged efforts to re-establish life sustaining cardiac and pulmonary function 
(e-CPR) [6, 7]. In this situation, percutaneous peripheral access to the groin vessels 
is the preferable approach in view of the continuation of chest compressions and 
limited equipment available (e.g. fluoroscopy, surgical set).
In patients with advanced cardiac failure ECLS may be used as a bridge to 
decision, recovery or heart transplantation. In some of these patients, particularly 
those awaiting transplantation or long-term VAD implantation it is used in a ‘semi-
elective emergency situation’ where patients are destabilising and showing signs of 
rapidly deteriorating end-organ function and impending cardiogenic shock. In this 
particular scenario ECLS is used to re-perfuse and stabilise end-organ function such 
as liver and kidney to allow for a non-emergency long-term VAD implantation at 
significantly less perioperative risk in a more stable patient. In this complex group 
of patients, peripheral access is favoured as it does not necessitate a sternotomy or 
thoracotomy leaving the chest ‘virgin’ or which may be complex due to previous, 
often multiple, surgical interventions. At the time of subsequent surgery ECLS can 
then easily be converted to CPB and continuation of ECLS post-surgery, if required 
[8, 9], can be achieved simply by switching back to an ECLS circuit.
In essence, peripheral access for the ECLS has become popular due to its flex-
ibility of implantation outside operation theatre, reduced cannula site bleeding, the 
option of chest closure, avoidance of chest re-exploration and explantation without 
chest intervention. With the overall increase in the utilisation of ECLS in PCCS, 
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post-PCI, e-CPR and as a bridge to transplant or ventricular assist devices and even 
as a bridge-to-lower risk surgery as a preparational tool, ECLS related complications 
including limb ischemia are being seen more often than ever before.
1.2 Incidence of limb ischemia
ECLS, essentially being temporary mechanical circulatory support requires an 
exit strategy with a sustainable solution, namely short or long-term ventricular 
assist device or transplant. Until then, an uninterrupted and uncomplicated distal 
limb perfusion is essential for the continuation of peripheral ECLS for more than a 
few hours. Any complications during the period on ECLS support potentially hin-
der patients’ progress to recovery or long-term solutions. Of these, limb ischemia 
is one of the notorious and unfortunately- most commonly encountered complica-
tions in patients supported. As with other complications, limb ischemia remains 
underreported in institutional audits and the literature and reported incidence of 
ECLS related limb ischemia vary significantly. The Extra-corporeal Life Support 
Organisation (ELSO) in its latest report shows 1% incidence of limb ischemia [12]. 
Whereas, a recent metanalysis reviewing 20 studies comprising 1886 patients 
revealed a pooled estimate of rate of limb ischemia as high as 16.9% (12.5–22.6%); 
compartment syndrome at 10.3% (7.3–14.5%) and amputation at 4.7% (2.3–9.3%) 
[13]. Other contemporary, smaller reviews report limb ischemia in range of 4.4–
19% and 11–52% [14, 15]. The variation among published literature in incidence 
of limb ischemia and related complications may be due to difference in inclusion 
criteria of patients, difference in definition of limb ischemia and publication bias.
1.3 Causes and presentation spectrum of limb ischemia
Limb ischemia has a broad spectrum of presentation ranging from hypothermia 
to muscle necrosis. In patients on ECLS it may occur for a number of reasons. Of 
these, the first and foremost is, of course, the simple complete obstruction of the 
femoral artery by the systemic perfusion cannula, which is inserted in a retrograde 
fashion, either percutaneously or open. The second is the requirement of extensive 
vasoconstrictor and inotropic support, which may restrict the ‘residual’ flow to 
the limb to the point of induction of clinically relevant ischemia. The third is the 
result of a deterioration of remaining cardiac output and loss of pulse wave, as the 
limb may be perfused—adequately—during the systolic ejection and be completely 
ischemic should pulse-wave be lost. Finally, insertion of the venous cannula on the 
ipsilateral side may result in clinically relevant venous congestion by itself and thus 
exacerbate any arterial perfusion deficit. Thus, careful monitoring and adjustment 
of several variables is essential in the prevention of ischemia and the treatment 
must be aimed at not only correcting the underlying causation but also to mitigate 
the resulting effects as in necrosis or reperfusion induced injury.
The signs and symptoms of acute limb ischemia are classically described with 
the 6 Ps- Pain, Pallor, Pulselessness, Paraesthesia, Poikilothermia, and Paralysis 
[16]. In this context, Rutherford’s grading of acute limb ischemia depending 
upon the clinical examination namely viable, threatened (salvageable if promptly 
treated) and irreversible (major tissue loss or permanent nerve damage inevitable) 
is helpful to determine the timing and type of intervention. The onset of fixed 
mottling of the skin usually implies irreversible changes but does not allow for an 
estimation as to the extent. Compartment syndrome results from increased pres-
sure (greater than 30–45 mmHg) in the muscle compartments often due to ischemia 
or reperfusion related swelling which further decreases blood supply leading to 
a vicious cycle of swelling-ischemia-swelling, rapidly progressing to irreversible 
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necrosis of the affected muscles. Diagnosis is essentially clinical with findings of 
swelling, stiffness, pain, and loss of pulse. It is a limb and life-threatening emer-
gency and is usually fatal unless immediate action is undertaken, almost always 
including four compartment fasciotomies [17].
Limb ischemia compromises survival not only of the involved limb but also the 
patient. The ischemic process, multiple procedures, and transfusions exacerbate 
the systemic inflammatory response related to ECLS, resulting in increased risk 
of death [18]. Tanaka et al. report a higher number of procedures per patient and 
an increased frequency of disseminated intravascular coagulation in patients with 
vascular complications [19]. They also found the rate of survival to discharge as 
18 vs. 49% in patients with and without vascular complications, respectively, 
demonstrating vascular complications as an independent factor of survival in 
patients on VA ECLS [19]. While some authors did not find any correlation between 
limb ischemia and patient mortality [20–22], it is widely accepted that apart from 
severity of the underlying condition, neurological uncertainty, and eligibility for 
substantive therapy, the limb ischemia plays a seminal role in deciding fate of the 
patient supported on ECLS.
2. Prevention of limb ischemia
2.1 Prophylactic distal perfusion cannula
Several authors highlight the role of concurrent, prophylactic, selective distal 
limb perfusion from the time of femoral arterial cannulation for systemic perfusion 
in the prevention of limb ischemia. In one series, the authors claim no occurrence of 
limb ischemia in patients with prophylactic distal perfusion via selective cannula-
tion (DPC) compared to a 21% incidence of ischemia in patients without DPC [21]. 
Tanaka et al. demonstrated that the absence of DPC was a significant predisposing 
factor for vascular complications, while other factors including medical history or 
risk factors like peripheral vascular disease and severity of baseline condition were 
not significantly associated with vascular complications [19]. However, from the 
review of published literature it is difficult to ascertain whether the elective avoid-
ance of DPC or the presence of factors preventing its use (e.g. peripheral artery 
disease, vessel spasm, vessel injury due to attempted cannulation) are the underly-
ing cause of the vascular complication.
In a comparative study, no limb ischemia was encountered in patients undergo-
ing pro-active DPC in contrast to 9.3% incidence of limb ischemia in patients who 
underwent re-active DPC as a rescue strategy. They concluded that the delayed 
distal cannulation not only increased the extent of cannulation site bleeding, but 
also failed as a rescue therapy as it failed to improve the ischemia [23] whereas pro-
active DPC prevented its occurrence. In addition, patients in the pro-active group 
demonstrated a significantly better weaning rate as well as survival.
However, despite extensive literature advocating DPC as being preventive to 
limb ischemia, there is no class I evidence about its efficacy. Understandably, it 
is difficult to design a randomised trial to identify actual protection offered by 
prophylactic DPC given the multiple factors responsible for mortality and morbid-
ity and grave condition of patients supported on VA-ECMO.
Although DPC offers incessant perfusion to the distal limb, its insertion and 
maintenance are not always smooth, and it is not devoid of complications. The DPC 
due to their small calibre, slow and low flow, acute angles, multiple connections are 
prone to bending, thrombogenesis, and peripheral embolization. It is important to 
note that DPC blockage due to thrombosis may go unnoticed in absence of continuous 
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monitoring of its flow and result in complete thrombo-embolism and obstruction of 
the femoral artery. In order to avoid this scenario and assess whether limb perfusion 
remains adequate in the absence of DCP, Huang et al. measured the pressure in the 
superficial femoral artery distal to the systemic cannula and introduced the DPC only 
when this pressure was less than 50 mmHg [24]. In their cohort of 26 patients, only 9 
patients fulfilling this criterion required the DPC and authors report no limb ischemia 
in any patients, with or without DPC. These findings are interesting and warrant 
further evaluation of their technique and confirmation by other study groups.
Compared to open cut-down DPC related complications are more common after 
percutaneous cannulation, often due to multiple cannulation attempts causing 
vessel injury, extravasation, hematoma and inadvertent cannulation of the profunda 
femoris. In contrast, while not ubiquitously feasible, technically more challenging 
and more time consuming, the open cut-down allows visualisation of the artery to 
ensure an adequate size of the cannula, proper placement, good haemostasis and 
the abandonment of the site without failed attempts in case of arterial calcifications 
[15]. Not surprisingly, a significantly higher incidence of limb ischemia was found 
in patients with a percutaneous DPC compared to patients with no DPC and open 
cut-down DPC in a series published by the Philadelphia group [25]. In this context, 
it is worth mentioning the ‘chimney graft construction’ approach on the femoral 
artery in which a small vascular graft is placed end-to side onto the main femoral 
artery, thus allowing for bi-directional perfusion without obstruction of the vessel. 
This avoids the more complex V-A-DPC-ECLS circuit, the DPC itself and its compli-
cations [26]. However, while avoiding ischemia and advocated for small femoral 
arteries, in bigger vessels it may lead to distal limb hyper-perfusion [15] (Table 1).
A generalised and enthusiastic approach for prophylactic DPC should be care-
fully reviewed and implemented only in cases with high risk for limb ischemia. These 
include patients with a history and signs of peripheral vascular disease, atherosclerosis, 
previous utilisation of groin vessels for access and female gender due to smaller vessel 
size as they are more prone to develop limb ischemia. In addition, young age may be an 
independent risk factor due to the absence of collateral vascularisation [21]. Also, there 
are several variables influencing the of risk of development of limb ischemia which 
can be addressed separately. These include low or no cardiac output resulting in loss of 
the pulse wave, although in patients with failure to oxygenate blood via the lung a low 
or absent biological output may be intended to prevent a watershed phenomenon and 
ensure cerebral oxygenation. High vasopressor support, peripheral shut-down and 
big calibre flow-occlusive systemic femoral cannulation are other factors influencing 
perfusion to distal limb and the development of limb ischemia.
As the principal role of the ECLS is temporary cardio-pulmonary support and 
preservation of organ perfusion, sufficient ‘biomechanical’ output can be provided 
often at a reasonable mechanical flow rate without complete replacement of the 
biological cardiac output. Cannulation with a small calibre systemic cannula may 
therefore provide enough flow and preserve a pulse wave allowing for sufficient 
perfusion of the distal limb. A 17F systemic cannula easily provides 4–5 L/min flow 
with a driving pressure of around 100 mmHg. Takayama et al. compared outcome 
in patients based on the size of the systemic cannula and showed that a 15F size 
cannula, while allowing for significantly less blood flow when compared to bigger 
(17–24F) cannulas, resulted in no difference in use of vasoactive medication, hemo-
dynamic parameters or laboratory values measured [27]. On the other hand, signifi-
cantly less cannulation-related adverse events were observed in the 15F group.
Patients on ECLS support may develop severe vasoplegia requiring high dose 
vasopressor support to sustain arterial blood pressure for satisfactory end-organ 
perfusion. Efforts to maintain a negative fluid balance to reabsorb peripheral and 
pulmonary oedema in a bid to wean ECLS may intensify vasopressor requirement 
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further. While maintaining central blood pressure levels, capillary perfusion of 
end organs, specifically the intestine as well as the limbs may be significantly 
reduced in such a scenario. Therefore, it is important to strike a balance between 
vasopressor delivery dependent blood pressure management, maintenance of 
fluid balance, arterio-venous perfusion pressure delta and capillary delivery, 
prioritising vasopressor weaning over ‘drying up the lungs’. Maintenance of good 
intravascular volume also allows better ECLS flow and cardiac output along with 
pulsatility.
In essence, utilisation of a small calibre systemic femoral cannula, when pos-
sible, acceptance a biomechanical output with low ECLS flow, continued pulsatile 
flow and avoidance of high dose vasopressors obviate the need for prophylactic 
DPC insertion in patients, potentially protecting them from DPC related complica-
tions. With this conservative management and a protocol of continuous, diligent 
monitoring, patients that develop limb ischemia can then be detected at an early 
stage and treated with subsequent DPC, if necessary.
Prevention of limb ischemia
Implantation
Cut down and under vision cannulation whenever feasible
Percutaneous cannulation only with USG/Fluoroscopy
Use of small calibre systemic arterial cannula
Use of Prophylactic distal arterial perfusion cannula
Use of Prophylactic distal venous drainage cannula
Utilise contralateral limb for venous drainage cannula
Maintenance
Bear high suspicion for ischemia
Accept low ECLS flow when possible to reduce cannula size
Maintain left ventricular ejection
Maintain pulsatile flow
Wean vasopressors as soon as possible
Selective infusion of prostacyclin via distal perfusion cannula
Keep patient awake- can complain of limb pain (ischemia)
Suspect limb ischemia if serum Lactate levels high
Achieve and maintain good anticoagulation
Monitoring
Near infra-red spectroscopy in distal limb
Continuous measurement of DPC flow
Doppler Ultrasound of distal limb arteries
Temperature
Explantation
Prefer open cut-down and repair of vessels
Perform balloon thrombo-embolectomy
Avoid groin compression
Table 1. 
Prevention of limb ischemia.
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2.2 ECLS and DPC implantation strategies
The individual approach of ECLS implantation heavily depends upon the place 
(out of the hospital, floor, bedside or operation theatre), urgency (elective or emer-
gency), and aetiology (PCCS, post-PCI, primary graft failure or bridge to trans-
plant) of the cardio-respiratory failure. In patients with cardiopulmonary arrest 
under resuscitation or peri-arrest patients, quick introduction of ECLS through is of 
utmost importance in order to sustain the patient’s life. In this situation, the primary 
goal is the insertion of systemic arterial and venous cannulas and there may not be 
time for simultaneous DPC insertion. Such emergency bedside ECLS implantation 
in the intensive therapy unit is a scenario that usually does not offer facilities of an 
operation theatre making percutaneous insertion of peripheral cannulas necessary 
(Figure 1), often without availability of sonography to appropriately size for the 
smallest cannulae or fluoroscopy for intravascular positioning. In this context, it is 
important to note that percutaneous insertion of the DPC can be challenging in the 
presence of a systemic arterial cannula already in place, either due to the reduction 
or even absence of blood flow distal to the cannulation site or vasospasm and vessel 
injury during primary cannulation. Nevertheless, if it is attempted, ultrasound 
guidance during insertion is helpful and angiographic confirmation of DPC tip 
position in the superficial femoral artery should be obtained [25, 28].
PCCS is a scenario usually encountered after complex and long operations 
and has an extreme mortality. While ECLS is the only treatment option for these 
patients, it is important to make the decision to use it as early as possible and avoid 
repeated and prolonged attempts to wean the patient of CPB as these cause consid-
erable collateral damage. ECLS should not be viewed as a last resort after all else has 
failed and the patient is in a catastrophic state but rather as a tool to be proactively 
used to ensure protection of organ function, continuous, uninterrupted sufficient 
perfusion and maintenance of a functioning coagulation system, thus preventing 
the well-known ICU exsanguination of these patients and offering both the heart as 
well as the patient a reasonable chance to recover.
For this, CPB can be converted directly to central ECLS, using the established 
cannulation or to peripheral ECLS. Peripheral ECLS allows the chest to be fully 
closed and no re-opening is needed for explantation of the ECLS system or for 
cannula-site bleeding especially in these patients on anti-coagulation therapy. With 
the patient stable on CPB it is safe and easy to perform a cut down to the groin 
vessels and placement of the cannulas under direct vision (Figure 2). If necessary, 
DPC can be introduced simultaneously. If the myocardial function is somewhat 
preserved, ECLS flows should be kept at a level allowing for blood flow through the 
heart to maintain left ventricular ejection in order to prevent its dilatation, stasis of 
Figure 1. 
Percutaneous cannulation.
8Advances in Extracorporeal Membrane Oxygenation - Volume 3
blood and possible atrial and ventricular thrombus formation. In severe myocardial 
injury, the heart can be rested with full ECLS flow without ejection. In this case, the 
need for ventricular decompression should be discussed. With biological no-flow, 
a case of high vasopressor requirement or expected longer duration of support, the 
DPC can introduced at the same time.
Peri or post-PCI, with fluoroscopy readily available, all ECLS cannulas can be 
introduced percutaneously and their position be confirmed before the patient 
leaves the cath-lab. ECLS as a bridge to transplant in awake patients is a recent trend 
that offers early ambulation and avoids ventilator-associated complications [29]. 
However, bedside ECLS can be challenging as a cut down is not comfortable in such 
patients and difficult outside the environment of the operating theatre. In these 
patients, the systemic arterial and venous cannulae are introduced percutaneously 
under local anaesthesia or the patient undergoes a short analgo-sedation as full 
sedation may be too high risk. As a general principal, contralateral femoral arterial 
and venous cannulation should be encouraged, as the venous stasis and possible 
limb oedema caused by the venous cannula may intensify any ipsilateral arterial 
cannula related compromised distal limb perfusion [15].
2.3 Expectant monitoring of limb
2.3.1 Continuous monitoring
Continuous diligent monitoring of the limb for any signs of ischemia is a key to 
allow for timely and appropriate intervention. One elegant and inexpensive method 
of continuous monitoring is placing an additional pulse-oximetry probe on the 
toes of the cannulated limb. Its reading and waveform can be compared with the 
probe placed on the normal limb. However, hypothermia and non-pulsatile flow 
may not offer reliable pulse-oximetry reading. Near infra-red spectroscopy (NIRS), 
routinely used and established in transcranial cerebral oximetry can be helpful 
in such cases and is an alternative method for continuous monitoring. It involves 
application of sensor pads on the legs that detects regional oxygen saturation (rSO2) 
Figure 2. 
Open cut-down cannulation.
9Isn’t Limb as Precious as Life?
DOI: http://dx.doi.org/10.5772/intechopen.86391
continuously, representing adequacy of tissue oxygenation. It should be applied 
as soon as ECLS is started. The rSO2 of the cannulated limb is compared with that 
of the opposite limb as well as with the baseline rSO2 providing live evidence of 
a drop in limb perfusion (Figure 3). A reduction in rSO2 values in the cannulated 
limb to less than 40 or more than 25% from baseline suggest inadequate limb 
perfusion and mandates urgent intervention [30, 31]. Technical glitches, however, 
like improper sensor pads attachments should be addressed before attempting to 
improve distal limb perfusion. Dong and colleagues utilised the NIRS successfully 
in a group of ECLS patients to detect and successfully treat limb ischemia with DPC 
in all patients having NIRS whereas 13.9% of the cohort not monitored required a 
fasciotomy [31]. Indeed, NIRS may reliably detect limb ischemia before it becomes 
clinically evident [31, 32]. Lamb et al. suggest continuous monitoring of limb utilis-
ing NIRS and evaluation of pedal doppler signals in case of a drop in baseline NIRS 
values to ensure adequate distal limb perfusion [33]. If available, we suggest that 
NIRS should be part of the protocol for peripheral ECLS.
In presence of DPC, continuous monitoring of its trans-canullar flow is the gold 
standard in monitoring distal limb perfusion (Figure 4). The DPC flow is depen-
dent on a variety of factors, namely total ECLS flow, mean arterial pressure and sys-
temic and peripheral vascular resistance, and possible thrombo-embolic occlusion 
in the DPC or distal artery. Therefore, any drop in the DPC flow must be correlated 
with these factors before any intervention. A drop in the DPC flow should also be 
cross-checked with the clinical signs of limb ischemia and drop in NIRS rSO2. An 
hourly record of the DPC flow along with other ECLS parameters should be main-
tained and perfusionists should be alerted if there is a significant change. Cannula 
or connecting line bending, thrombosis and dislocation are common non patient 
related reasons for decreased DPC flow. Both antegrade and retrograde blood flow 
should be checked by clamps on either side of DPC side-port [10]. In the absence of 
a side-port, the DPC may have to be disconnected to assess for backflow through the 
cannula and appropriate flow in the proximal line. Thrombosis in the DPC is usually 
accompanied by embolization into the distal femoral artery and mandates embo-
lectomy and DPC replacement. Only in the minority of cases it can be addressed by 
aspiration of the thrombotic material.
2.3.2 Hourly monitoring
Despite continuous monitoring of limb perfusion by means of NIRS and DPC flow, 
hourly inspection for skin colour change, palpation for temperature, capillary return 
at toe tips, calf palpation and calf girth measurement for compartment syndrome is 
of paramount importance. Pedal pulses should be checked in the dorsalis pedis and 
Figure 3. 
NIRS continuous monitoring.
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posterior tibial artery and when not palpable a hand-held ultrasound Doppler should 
be utilised to confirm the flow. The flow may be graded for documentation as palpable- 
strong pulsatile, palpable- weak pulsatile, doppler- pulsatile, doppler- continuous flow 
and absent flow. Hourly recording of continuously monitored variables namely DPC 
flow, NIRS rSO2 are necessary to establish trends and detect limb ischemia before it is 
clinically apparent. Numbers and signs that may be missed during continuous monitor-
ing can be caught in a vigilant hourly survey. Ischemia in toes is seen not uncommon, 
even in the presence of well-maintained DPC flow due to peripheral micro thrombo-
embolization and/or vasospasm due to peripheral shut down or high dose vasopressors.
2.4 Early detection of limb ischemia
Early detection of inadequate limb perfusion allows for immediate intervention 
to avoid its catastrophic consequences. In absence of the DPC, continuous NIRS 
monitoring supplemented by an hourly survey by means of clinical examination 
and Doppler ultrasound flow check in the distal arteries is usually adequate to detect 
limb ischemia at an early stage. NIRS rSO2, clinical signs and ultrasound Doppler 
flow in the cannulated limb should be compared with opposite limb, not to confuse 
ischemia with peripheral shut down and peripheral vasospasm. In patients with a 
prophylactic or therapeutic introduction of DPC, it is important to remember that 
the DPC does not guarantee adequate perfusion. Thus, continuous measurement of 
DPC flow, maintenance of adequate anticoagulation and monitoring of actual limb 
perfusion remains essential. Awake non-intubated, non-sedated patients supported 
on ECLS may complain of pain, tingling- numbness or stiffness with the onset of 
limb ischemia. An increase in lactate levels without an attributable source and acute 
kidney failure may be signs of subclinical rhabdomyolysis and should immediately 
Figure 4. 
Continuous DPC flow monitoring.
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raise suspicion of ischemia. Finally, signs of ischemia may be seen only in the toes, 
even with a good DPC flow due to peripheral embolization through DPC.
2.5 Explantation
ECLS is a lifesaver for patients with compromised cardiopulmonary function; 
however, it may instigate life-threatening complications and the incidence of 
complications increases with increase in duration of the ECLS. Yoe et al. found the 
duration of ECLS more than 7 days is a factor associated with the development of 
limb ischemia [23]. Therefore, weaning of ECLS should begin with recovery of vital 
organ function with the aim of its explantation as soon as possible. Extra caution is 
mandated during weaning of patients with the DPC, as the decrease in total ECLS 
flow decreases DPC flow that may lead to inadequate limb perfusion as well as 
thrombosis of the DPC. In this situation, the DPC flow should be maintained around 
at least 300 ml/min by applying a gate clamp on the retrograde arterial cannula. 
Explantation of ECLS at the end of successful weaning should be performed as an 
elective case in the operation theatre. The vessels are exposed and controlled with 
slings before removal of cannulas. Embolectomy is attempted multiple times with 
balloon tip catheters till satisfactory retro and antegrade blood flow is achieved. The 
artery is then repaired with or without a patch or an interposition graft to main-
tain its original calibre without flow limitation. The limb is monitored for at least 
48 hours following ECLS explantation for any signs of residual or fresh ischemia.
3. Treatment of limb ischemia
Traditionally, 6 hours are recommended as a golden period for intervention in 
limb ischemia. In a series analysing limb ischemia in ECLS patients an additional 
retrograde reperfusion within 6 hours of onset of symptoms avoided amputations 
completely, whereas the same procedure after that period was burdened with a 20% 
amputation rate or permanent neurological deficit [34]. Therefore, every attempt 
should be made to re-establish adequate blood supply in the ischemic limb as soon 
as possible to avoid catastrophic consequences and residual damage (Table 2).
3.1 Therapeutic insertion of distal perfusion cannula
Limb ischemia due to inadequate flow in the distal artery detected at early 
stage ideally should be treated with the introduction of the DPC if not placed at 
ECLS implantation. Apart from conscious avoidance, reasons for not introducing 
Management of established limb ischemia
Introduce distal perfusion cannula (DPC)- cut down
Percutaneous DPC- Check position with fluoroscopy
Continuous Epoprostenol in DPC
Thrombo-embolectomy
Change of cannulation site
Decompression compartment fasciotomy
Amputation
Table 2. 
Management of limb ischemia.
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prophylactic DPC are among others: failed percutaneous insertion, atherosclerotic 
plaque palpated in open cut-down and need to return to the intensive care unit for 
patient stabilisation. In a metanalysis reviewing 22 retrospective studies comparing 
peripheral ECLS with or without DPC, the presence of a DPC was associated with at 
least a 15.7% absolute reduction in the incidence of limb ischemia; although without 
any impact on the patient survival [35].
Several cannulas from an introducer sheath up to a paediatric arterial cannula 
are recommended in the literature for this purpose. An ideal is the one that is resis-
tant to bending and thrombosis and offering a least resistance to flow. We found 
the incidences of limb ischemia and limb ischemia requiring surgical intervention 
were significantly higher for the introducer sheath compared with the 10–12F Bio-
Medicus® paediatric seldinger cannula utilised for distal limb perfusion (30.6 vs. 
15.6% and 15.4 vs. 6.25%, respectively) [11].
To introduce the DPC percutaneously, the superficial femoral artery may be 
visualised distal to the systemic cannula via Ultrasound. If this is not possible, a 
cut-down insertion should be performed. If introduced bedside, especially percuta-
neously, the position of the DPC should be confirmed via x-ray.
3.2 Continuous infusion of anticoagulants and vasodilator drugs
Any ECLS circuit exposes blood to non-biological surfaces and is in itself throm-
bogenic. Therefore, adequate anticoagulation, usually achieved by continuous 
intravenous delivery of unfractionated heparin is essential to prevent complications 
such as thrombus formation and clotting of the circuit and stroke, limb and bowel 
ischemia. Conventionally heparin is delivered via a central venous catheter. As the 
small arteries of the distal limb are specifically at risk of micro-thrombotic clotting 
complications a targeted delivery of anticoagulants may offer a strategy to prevent 
distal ischemia. Continuous heparin delivery in the ECLS circuit before oxygenator 
at beginning of ECLS should be considered in any institutional protocol.
Due to the discrepancy in size of the aorta and distal superficial femoral artery 
as well as resistance between the systemic cannula and the DPC, there is a signifi-
cant discrepancy in the flow rate between them, sometimes resulting in very little 
or almost no flow through the for DPC. In these cases, a gate clamp on the systemic 
arm can be helpful; however, it may cause flow turbulence, is potentially thrombo-
genic and increases driving pressure in the system.
Alternatively, and already mentioned above, Epoprostenol, a potent vasodila-
tor, which is established in the treatment of peripheral vascular disease, can be 
delivered directly into the limb via DPC side-port in order to induce peripheral 
vasodilatation and increase perfusion. Some paediatric aortic cannulas have a side-
port that can be readily used for this purpose [10]. Otherwise, a 3/8–3/8″ connector 
with a side-port can be inserted into the arm feeding the DPC. In some patients this 
may result in an increased requirement of vasopressors to maintain central arterial 
pressure. As a word of caution, selective infusion of vasodilators may also result 
in hyper-perfusion and clinically relevant oedema, especially in presence of an 
ipsilateral venous cannula.
3.3 Change of cannulation site
Peripheral access for ECLS seek mainly due to urgency or bedside scenario is 
converted to central access once patient is stabilised or develops complication due 
to peripheral cannulation. One of the strategies in suspected or established limb 
involves shifting the arterial cannulation site followed by embolectomy and, if neces-
sary, repair of the vessel. In many cases this may be the ascending aorta, as this offers 
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certain advantages such as oxygenated blood supply to coronaries and avoidance 
of any watershed phenomenon, even in patients with compromised lung function. 
Also, the opposite superficial femoral artery or axillary artery may be utilised if the 
treating physician wants to avoid sternotomy or cannulation of the aorta is difficult. 
In patients with acceptable lung function and compromised cardiac function, ECLS 
can be converted into a uni- or bi-ventricular short-term ventricular assist device 
at this time avoiding the further use of the oxygenator and thus allowing for a less 
stringent anticoagulation regime and easier mobilisation of the patient.
3.4 Management of advanced limb ischemia
Fasciotomy is a decompression manoeuvre performed on the limb with acute com-
partment syndrome, a surgical emergency. Release of pressure allows reperfusion of the 
ischemic muscles potentially avoiding amputation. A recent metanalysis consisting 1886 
patients found 10% incidence of compartment syndrome requiring fasciotomy [13]. 
ECLS Implantaon
Limb ischemia
Early intervenon
Introduce DPC
Change cannulaon site
Bridge to substanve therapy
Open cut-down cannul.
Operaon theatre
Percutaneous cannul.
Cath-lab
Bedside
Check fluoroscopy for 
locaon of DPC p
Prophylacc DPC
Peripheral vascular disease
Young age
Female gender
Consider small systemic cannula
Accept low (adequate) ECLS flow
Maintain pulsale flow
Avoid DPC
Small systemic cannula
Pulsale flow
Wean vasopressors
Vigilant monitoring 
Monitoring
Connuous: NIRS, DPC flow
Hourly survey: Ischemia signs, 
doppler flow check in distal arteries
Figure 5. 
Protocol for management of limb ischemia.
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 Several authors confirm that the procedure is effective provided it is performed as 
soon as the diagnosis of compartment syndrome is established. It can be performed 
bedside under local anaesthesia [36, 37]. Four chamber fasciotomies essentially involve 
decompression of anterior and posterior compartment of the thigh and anterolateral 
and posteromedial compartments of lower leg. Primary closure of these wounds can be 
performed following explantation of ECLS and decrease of limb swelling.
A last and unfortunate resort in the management of advanced limb ischemia to save 
a life is to give up a limb. Irreversible ischemic damage to skin and muscles causes rhab-
domyolysis, acute kidney injury, and metabolic acidosis. In such cases, amputation of 
the limb remains the only option to save the patient’s life. Contemporary retrospective 
observational studies report incidence of lower limb amputation in patients supported 
with ECLS between 1 to 10% [11, 13, 15, 20, 21, 38]. However, some prospective studies 
with utilisation of newer technology and ideas such as NIRS for early detection of isch-
emia and distal arterial pressure based or pre-emptive introduction of DPC reported 
no amputations [23, 24, 31]. However, apart from the obvious benefit of these newer 
techniques, patients in studies focusing on limb ischemia may have received significant 
additional attention and care to prevent and treat limb ischemia at early stage. This in 
itself may have had a profound effect, further corroborating that early detection of 
limb ischemia with expectant monitoring and protocol-based prompt intervention 
may avoid its catastrophic consequences (Figure 5).
4. Conclusions
Care of the cannulated limb with maintenance of adequate perfusion to avoid isch-
emia is as important as the preservation of vital organ function. Limb ischemia plays 
a seminal role in the fate of a patient supported on ECLS. Vascular complications, 
particularly limb ischemia negatively affect survival in patients on ECLS. Expectant 
continuous monitoring utilising NIRS, if used, a flow monitored distal perfusion 
cannula and hourly surveys of flow in distal arteries and signs of ischemia are key in 
timely detection of limb ischemia. A prophylactic distal perfusion cannula should 
always be used in patients with risk factors for development of limb ischemia and can 
most likely be avoided in others if a small calibre systemic cannula is used. Acceptance 
of lower ECLS flow, maintenance of pulsatility and avoidance of vasopressors are 
additional important elements. Prompt intervention to re-establish adequate blood 
supply after suspicion of limb ischemia is essential to avoid its catastrophic conse-
quences. The safest method of prophylactic or therapeutic introduction of a distal 
perfusion cannula remains the open cut-down and exposure. Percutaneously inserted 
distal perfusion cannulas should be checked for their position by fluoroscopy. Also, 
change of cannulation site and bridging ECLS to a substantive therapy should be 
part of any strategy for patients on ECLS. If properly integrated into an institutional 
protocol and adhered to, these strategies allow for successful treatment of patients in 
need of extracorporeal life support with low complication and high success rates.
Acknowledgements
Authors are not funded for preparation of this manuscript. Authors thank Olaf 
Maunz for helping with manuscript editing.
Conflict of interest
Authors do not have any conflicts of interest.
15
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Isn’t Limb as Precious as Life?
DOI: http://dx.doi.org/10.5772/intechopen.86391
Author details
Prashant N. Mohite* and André R. Simon
Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital,  
United Kingdom
*Address all correspondence to: p.mohite@rbht.nhs.uk
16
Advances in Extracorporeal Membrane Oxygenation - Volume 3
[1] Thiagarajan RR, Barbaro RP, 
Rycus PT, Mcmullan DM, Conrad SA, 
Fortenberry JD, et al. Extracorporeal 
life support organization registry 
international report 2016. ASAIO 
Journal. 2017;63(1):60-67
[2] Khorsandi M, Dougherty S,  
Bouamra O, Pai V, Curry P, Tsui S, et al. 
Extra-corporeal membrane oxygenation 
for refractory cardiogenic shock after 
adult cardiac surgery: A systematic 
review and meta-analysis. Journal of 
Cardiothoracic Surgery. 2017;12(1):55
[3] Pappalardo F, Montisci A. Veno-
arterial extracorporeal membrane 
oxygenation (VA ECMO) in 
postcardiotomy cardiogenic shock: 
How much pump flow is enough? 
Journal of Thoracic Disease. 
2016;8(10):E1444-E1448
[4] Sung PH, Wu CJ, Yip HK. Is 
extracorporeal membrane oxygenator 
a new weapon to improve prognosis 
in patients with profound cardiogenic 
shock undergoing primary percutaneous 
coronary intervention? Circulation 
Journal. 2016;80:572-578
[5] Tsao NW, Shih CM, Yeh JS, et al. 
Extracorporeal membrane oxygenation-
assisted primary percutaneous coronary 
intervention may improve survival 
of patients with acute myocardial 
infarction complicated by profound 
cardiogenic shock. Journal of Critical 
Care. 2012;27:530. e1-530.e11
[6] Ortega-Deballon I, Hornby L, 
Shemie SD, Bhanji F, Guadagno E.  
Extracorporeal resuscitation for 
refractory out-of-hospital cardiac 
arrest in adults: A systematic review of 
international practices and outcomes. 
Resuscitation. 2016;101:12-20
[7] Tonna JE, Johnson NJ, Greenwood J, 
Gaieski DF, Shinar Z, Bellezo JM, 
et al. Extracorporeal REsuscitation 
ConsorTium (ERECT) Research 
Group. Practice characteristics of 
Emergency Department extracorporeal 
cardiopulmonary resuscitation 
(eCPR) programs in the United 
States: The current state of the art of 
Emergency Department extracorporeal 
membrane oxygenation (ED ECMO). 
Resuscitation. 2016;107:38-46
[8] Durinka JB, Bogar LJ, Hirose H, 
Brehm C, Koerner MM, Pae WE, et al. 
End-organ recovery is key to success for 
extracorporeal membrane oxygenation 
as a bridge to implantable left 
ventricular assist device. ASAIO Journal. 
2014;60(2):189-192
[9] Chung JC, Tsai PR, Chou NK, Chi NH, 
Wang SS, Ko WJ. Extracorporeal 
membrane oxygenation bridge to 
adult heart transplantation. Clinical 
Transplantation. 2010;24(3):375-380
[10] Mohite PN, Maunz O, Simon AR.  
Pearls and pitfalls in short-term 
mechanical circulatory assist: How 
to avoid and manage complications. 
Artificial Organs. 2014;38(10):829-837
[11] Mohite PN, Fatullayev J, 
Maunz O, Kaul S, Sabashnikov A, 
Weymann A, et al. Distal limb 
perfusion: Achilles' heel in peripheral 
venoarterial extracorporeal membrane 
oxygenation. Artificial Organs. 
2014;38(11):940-944
[12] Extracorporeal Life Support 
Organisation. ECLS Registry Report. 
Ann Arbor. 2017. Downloaded Nov 
2017
[13] Cheng R, Hachamovitch R, 
Kittleson M, Patel J, Arabia F, Moriguchi 
J, et al. Complications of extracorporeal 
membrane oxygenation for treatment 
of cardiogenic shock and cardiac arrest: 
A meta-analysis of 1,866 adult patients. 
The Annals of Thoracic Surgery. 
2014;97(2):610-616
References
17
Isn’t Limb as Precious as Life?
DOI: http://dx.doi.org/10.5772/intechopen.86391
[14] von Segesser L, Marinakis S, 
Berdajs D, Ferrari E, Wilhelm M, 
Maisano F. Prevention and therapy 
of leg ischaemia in extracorporeal 
life support and extracorporeal 
membrane oxygenation with peripheral 
cannulation. Swiss Medical Weekly. 
2016;146:w14304
[15] Roussel A, Al-Attar N, Khaliel F, 
Alkhoder S, Raffoul R, Alfayyadh F, 
et al. Arterial vascular complications in 
peripheral extracorporeal membrane 
oxygenation support: A review of 
techniques and outcomes. Future 
Cardiology. 2013;9(4):489-495
[16] Brearley S. Acute leg ischaemia. 
BMJ. 2013;346:f2681
[17] Tiwari A, Haq AI, Myint F, 
Hamilton G. Acute compartment 
syndromes. The British Journal of 
Surgery. 2002;89(4):397-412. Review
[18] Levi M. Current understanding of 
disseminated intravascular coagulation. 
British Journal of Haematology. 
2004;124:567-576
[19] Tanaka D, Hirose H, Cavarocchi N, 
Entwistle JW. The impact of vascular 
complications on survival of patients on 
venoarterial extracorporeal membrane 
oxygenation. The Annals of Thoracic 
Surgery. 2016;101(5):1729-1734
[20] Bisdas T, Beutel G, Warnecke G, 
et al. Vascular complicationsin patients 
undergoing femoral cannulation for 
extracorporeal membrane oxygenation 
support. The Annals of Thoracic 
Surgery. 2011;92:626-631
[21] Foley PJ, Morris RJ, Woo EY,  
Acker MA, Wang GJ, Fairman RM, 
et al. Limb ischemia during femoral 
cannulation for cardiopulmonary 
support. Journal of Vascular Surgery. 
2010 Oct;52(4):850-853
[22] Avalli L, Sangalli F, Migliari M, 
Maggioni E, Gallieri S, Segramora V,  
et al. Early vascular complications 
after percutaneous cannulation 
for extracorporeal membrane 
oxygenation for cardiac assist. Minerva 
Anestesiologica. 2016;82(1):36-43
[23] Yeo HJ, Yoon SH, Jeon D, Kim YS, 
Cho WH, Kim D, et al. The utility of 
preemptive distal perfusion cannulation 
during peripheral venoarterial 
extracorporeal membrane oxygenation 
support. Journal of Interventional 
Cardiology. 2016;29(4):431-436
[24] Huang SC, Yu HY, Ko WJ, Chen YS.  
Pressure criterion for placement of 
distal perfusion catheter to prevent limb 
ischemia during adult extracorporeal 
life support. The Journal of Thoracic 
and Cardiovascular Surgery. 
2004;128(5):776-777
[25] Vallabhajosyula P, Kramer M,  
Lazar S, McCarthy F, Rame E, Wald J, 
et al. Lower-extremity complications 
with femoral extracorporeal life 
support. The Journal of Thoracic 
and Cardiovascular Surgery. 
2016;151(6):1738-1744
[26] Jackson KW, Timpa J, McIlwain RB,  
et al. Side-arm grafts for femoral 
extracorporeal membrane oxygenation 
cannulation. The Annals of Thoracic 
Surgery. 2012;94:111-112
[27] Takayama H, Landes E, Truby L,  
Fujita K, Kirtane AJ, Mongero L, 
et al. Feasibility of smaller arterial 
cannulas in venoarterial extracorporeal 
membrane oxygenation. The Journal of 
Thoracic and Cardiovascular Surgery. 
2015;149(5):1428-1433
[28] Black MC, Slaughter MS. Proactive 
or reactive? Best approach to limb 
ischemia in peripheral venoarterial 
extracorporeal life support. The Journal 
of Thoracic and Cardiovascular Surgery. 
2016;151(6):1745-1746
[29] Mohite PN, Sabashnikov A, Reed A,  
Saez DG, Patil NP, Popov AF, et al. 
18
Advances in Extracorporeal Membrane Oxygenation - Volume 3
Extracorporeal life support in “Awake” 
patients as a bridge to lung transplant. 
The Thoracic and Cardiovascular 
Surgeon. 2015;63(8):699-705
[30] Wong JK, Smith TN, Pitcher HT, 
Hirose H, Cavarocchi NC. Cerebral and 
lower limb near-infrared spectroscopy 
in adults on extracorporeal membrane 
oxygenation. Artificial Organs. 
2012;36:659-667
[31] Kim DJ, Cho YJ, Park SH, Lim C, 
Park KH, Jheon S, et al. Near-infrared 
spectroscopy monitoring for early 
detection of limb ischemia in patients 
on veno-arterial extracorporeal 
membrane oxygenation. ASAIO Journal. 
2017;63(5):613-617
[32] Prkic I, Stuth EA. Near-infrared 
spectroscopy provides continuous 
monitoring of compromised lower 
extremity perfusion during cardiac 
surgery. Journal of Clinical Anesthesia. 
2016;31:38-41
[33] Lamb KM, DiMuzio PJ, Johnson A, 
Batista P, Moudgill N, McCullough M,  
et al. Arterial protocol including 
prophylactic distal perfusion catheter 
decreases limb ischemia complications 
in patients undergoing extracorporeal 
membrane oxygenation. 
Journal of Vascular Surgery. 
2017;65(4):1074-1079
[34] Spurlock DJ, Toomasian JM, 
Romano MA, Cooley E, Bartlett RH, 
Haft JW. A simple technique to prevent 
limb ischemia during veno-arterial 
ECMO using the femoral artery: The 
posterior tibial approach. Perfusion. 
2012;27:141-145
[35] Juo YY, Skancke M, Sanaiha Y, 
Mantha A, Jimenez JC, Benharash P.  
Efficacy of distal perfusion cannulae 
in preventing limb ischemia 
during extracorporeal membrane 
oxygenation: A systematic review 
and meta-analysis. Artificial Organs. 
2017;41(11):E263-E273
[36] Go JY, Min YS, Jung TD. Delayed 
onset of acute limb compartment 
syndrome with neuropathy after 
venoarterial extracorporeal 
membrane oxygenation therapy. 
Annals of Rehabilitation Medicine. 
2014;38(4):575-580
[37] Wall CJ, Santamaria J.  
Extracorporeal membrane oxygenation: 
An unusual cause of acute limb 
compartment syndrome. Anaesthesia 
and Intensive Care. 2010;38:5602
[38] Gander JW, Fisher JC,  
Reichstein AR, Gross ER, Aspelund G,  
Middlessworth W, et al. Limb 
ischemia after common femoral 
artery cannulation for venoarterial 
extracorporeal membrane oxygenation: 
An unresolved problem. Journal of 
Pediatric Surgery. 2010;45:2136-2140
